Research Article

Integration of Single-Cell Multi-omics and Machine Learning Identifies Predictive Biomarkers for Immunotherapy Response in Glioblastoma

117 reads
JO MO Bio Ino, 2026, 1 (2), 60-66, ISSN

Abstract

Glioblastoma (GBM) remains one of the most lethal primary central nervous system malignancies, characterized by profound intratumoral heterogeneity, profound immunosuppression, and resistance to immune checkpoint blockade (ICB). Despite aggressive multimodal interventions, therapeutic response rates to anti-PD-1/PD-L1 regimens remain dismal. In this study, we developed an integrative computational framework combining single-cell RNA sequencing (scRNA-seq) and single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq) data from 38 primary and recurrent GBM cohorts to identify cellular and epigenetic determinants of immunotherapy efficacy. By applying an ensemble machine learning architecture incorporating extreme gradient boosting (XGBoost) and graph neural networks, we resolved a distinct subpopulation of immunosuppressive SPP1+/CD163+ tumor-associated macrophages tightly coupled with exhausted TCF7lowHAVCR2high CD8+ T cells through aberrant ligand-receptor signaling axes. Furthermore, our machine learning pipeline prioritized an 8-gene transcriptional and chromatin accessibility signature—designated the Glioblastoma Immunotherapy Predictive Index (GIPI)—that robustly predicted ICB clinical response with an area under the receiver operating characteristic curve (AUC) of 0.912 in an independent validation cohort. Epigenetic motif enrichment revealed that the AP-1 and RUNX1 regulons drive the chromatin remodeling underlying therapy-refractory cellular states. Our findings demonstrate that integrating single-cell multi-omics with explainable machine learning uncovers actionable regulatory mechanisms and provides a clinically translatable biomarker panel for stratifying GBM patients undergoing immunotherapy.

Keywords Machine learning glioblastoma tumor microenvironment Single-Cell Multi-omics Immunotherapy Biomarkers
Authors 2

The team behind this paper

2 authors, 2 institutions.

This paper Korea Advanced Institute of Science and Technology (KAIST) — South Korea Korea Advanced Institut… 1 author Cairo University — Egypt Cairo University 1 author Prof. Sun-Woo Park — corresponding author SP Prof. Sun-Woo Park ✉ Dr. Amina El-Sayed AE Dr. Amina El-Sayed

Readership

117 reads over 3 months.

#10 most read in this journal this month
September 2026 November 2026

Bibliographic Information

Prof. Sun-Woo Park, Dr. Amina El-Sayed, (2026). Integration of Single-Cell Multi-omics and Machine Learning Identifies Predictive Biomarkers for Immunotherapy Response in Glioblastoma, SciMatic Journal of Molecular Bio-Innovations, 1(2): 60-66
Bibtex Citation
@article{prof._sun-woo_park2026jmbi,
author = {Prof. Sun-Woo Park and Dr. Amina El-Sayed},
title = {Integration of Single-Cell Multi-omics and Machine Learning Identifies Predictive Biomarkers for Immunotherapy Response in Glioblastoma},
journal = {SciMatic Journal of Molecular Bio-Innovations},
year = {2026},
volume = {1},
number = {2},
pages = {60-66},
doi = {},
url = {https://scimatic.org/show_manuscript/9835}
}
APA Citation
Park, P.S., El-Sayed, D.A., (2026). Integration of Single-Cell Multi-omics and Machine Learning Identifies Predictive Biomarkers for Immunotherapy Response in Glioblastoma. SciMatic Journal of Molecular Bio-Innovations, 1(2), 60-66. https://doi.org/

Author Information

  • To change your profile photo, login to scimatic.org, go to your profile and change the photo.
  • Any photo that shows your face will do: we crop it to your head and shoulders and give it a plain background automatically.
  • To sign in, go to Sign in and enter the e-mail address registered with the article: we e-mail you a one-time sign-in link (there is no password).
  • In case of any other problem, contact your editor directly or write to us at info @ scimatic.org